2000
DOI: 10.1016/s0304-3835(99)00379-1
|View full text |Cite
|
Sign up to set email alerts
|

Reduction of murine mammary tumor metastasis by conjugated linoleic acid

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
30
0
2

Year Published

2001
2001
2016
2016

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 71 publications
(32 citation statements)
references
References 26 publications
0
30
0
2
Order By: Relevance
“…Isomer t10, c12-18:2 a powerful inhibitor of the synthesis of fat in milk and responsible for the redistribution of fat in muscle, contributing to reduce the fat mass and increase the lean mass (Mourão et al, 2005;Dugan et al, 1997;Chardigny et al, 2003;Gaullier et al, 2005;Degrace et al, 2003). Isomer c9, t11-18:2 has demonstrated antitumoral properties, reducing the incidence of breast cancer (Mourão et al, 2005;Dugan et al, 1997;Chardigny et al, 2003;Gaullier et al, 2005;Degrace et al, 2003;Ou et al, 2007;Lavillonnière et al, 2003;Belury et al, 1996;Hubbard et al, 2000;Molkentin, 1999;Chardigny et al, 2008).…”
Section: Introductionmentioning
confidence: 99%
“…Isomer t10, c12-18:2 a powerful inhibitor of the synthesis of fat in milk and responsible for the redistribution of fat in muscle, contributing to reduce the fat mass and increase the lean mass (Mourão et al, 2005;Dugan et al, 1997;Chardigny et al, 2003;Gaullier et al, 2005;Degrace et al, 2003). Isomer c9, t11-18:2 has demonstrated antitumoral properties, reducing the incidence of breast cancer (Mourão et al, 2005;Dugan et al, 1997;Chardigny et al, 2003;Gaullier et al, 2005;Degrace et al, 2003;Ou et al, 2007;Lavillonnière et al, 2003;Belury et al, 1996;Hubbard et al, 2000;Molkentin, 1999;Chardigny et al, 2008).…”
Section: Introductionmentioning
confidence: 99%
“…Numerous studies using various animal models support the hypothesis that both synthetic and naturally enriched sources of CLA added to the diet inhibit mammary tumour initiation [18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34], promotion and progression [35][36][37][38][39][40][41] in rodents ( Table 2). A range of 0.1% to 1% w/w of CLA, independent of the level and type of fat in the diet, has shown to be effective, with no further benefits beyond 1% w/w [19,24].…”
Section: Animal Studies Of Cla and Mammary Cancermentioning
confidence: 97%
“…An inhibitory effect of CLA has been reported at different stages: initiation, promotion and tumourgrowth [30], and metastasis formation [31]. Prepubescent female rats supplemented with CLA before carcinogen induction [dimethylbenz(a)anthracen (DMBA) or N-methyl nitroso urea (NMU)] developed significantly fewer mammary tumours than the control rats (47%) [27], suggesting that the presence of CLA within mammary tissues made them less sensitive to initiation by a carcinogenic agent.…”
Section: Cla and Mammary Tumorigenesismentioning
confidence: 98%